Tacalyx
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- $28M
Investors
- 8
About Tacalyx
a. Tacalyx developing novel antibody-based cancer therapies by targeting tumour-associated carbohydrate antigens (TACAs), an underexplored class of highly specific tumour cell surface markers.a. Tacalyx is a biotechnology company that develops therapeutics to target cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors. Jean Engela is serving the role of CEO. Tacalyx develops anticancer therapeutics that target tumor-associated carbohydrate antigens (TACAs). These antigens, typically found in embryonic development and highly expressed in tumors, serve as targets for novel immunotherapies. Tacalyx's pipeline includes various treatment modalities, such as antibody-drug conjugates and T cell engagers, aimed at different TACAs across multiple solid tumors. Tacalyx GmbH is an early-stage biotech company that does not generate significant commercial revenue. Future revenue is expected from licensing deals, strategic partnerships, or commercialization milestones tied to its antibody-based cancer therapies.
Who invested in Tacalyx
8 investors across 3 rounds
See all investors in Tacalyx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tacalyx
Who invested in Tacalyx?
Tacalyx has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tacalyx raised?
Tacalyx has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Tacalyx last raise money?
Tacalyx's most recent round on record is a Series A, in Mar 2026.
What does Tacalyx do?
Tacalyx is a biotechnology company.
Where is Tacalyx headquartered?
Tacalyx is headquartered in Berlin, Germany.
Which VCs invest in companies like Tacalyx?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Tacalyx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tacalyx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.